Edgewise Therapeutics, Inc. (EWTX)
42.02
-1.66
(-3.80%)
USD |
NASDAQ |
Nov 17, 16:00
42.02
0.00 (0.00%)
After-Hours: 16:16
Edgewise Therapeutics Price : 42.02 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 45.00 | 46.00 | 43.30 | 43.68 | 1.280M |
| Nov 13, 2026 | 45.72 | 46.75 | 44.08 | 45.93 | 1.162M |
| Nov 12, 2026 | 46.46 | 46.93 | 45.04 | 45.82 | 1.097M |
| Nov 11, 2026 | 46.28 | 47.84 | 45.54 | 47.57 | 1.343M |
| Nov 10, 2026 | 46.82 | 47.79 | 44.79 | 46.53 | 1.940M |
| Nov 09, 2026 | 45.60 | 48.78 | 44.58 | 48.74 | 2.589M |
| Nov 06, 2026 | 39.71 | 45.76 | 38.04 | 45.04 | 3.715M |
| Nov 05, 2026 | 43.00 | 43.25 | 36.72 | 38.87 | 5.217M |
| Nov 04, 2026 | 38.96 | 39.48 | 37.39 | 37.53 | 1.081M |
| Nov 03, 2026 | 38.73 | 40.41 | 36.70 | 37.68 | 1.879M |
| Nov 02, 2026 | 38.93 | 39.75 | 37.46 | 38.11 | 1.084M |
| Oct 30, 2026 | 38.72 | 39.44 | 38.02 | 38.90 | 967632.0 |
| Oct 29, 2026 | 40.59 | 41.63 | 38.64 | 38.91 | 1.210M |
| Oct 28, 2026 | 39.53 | 40.56 | 38.66 | 40.49 | 1.633M |
| Oct 27, 2026 | 39.51 | 40.32 | 39.03 | 39.53 | 942050.0 |
| Oct 26, 2026 | 39.49 | 40.44 | 38.70 | 39.17 | 1.018M |
| Oct 23, 2026 | 39.91 | 39.91 | 38.90 | 39.31 | 911110.0 |
| Oct 22, 2026 | 39.11 | 40.68 | 38.36 | 39.99 | 1.338M |
| Oct 21, 2026 | 39.95 | 40.78 | 39.45 | 39.65 | 1.828M |
| Oct 20, 2026 | 38.03 | 40.32 | 37.88 | 39.75 | 2.171M |
| Oct 19, 2026 | 37.41 | 38.25 | 36.54 | 37.92 | 1.422M |
| Oct 16, 2026 | 38.28 | 38.28 | 36.70 | 37.19 | 1.305M |
| Oct 15, 2026 | 37.62 | 38.53 | 37.24 | 38.20 | 1.837M |
| Oct 14, 2026 | 35.93 | 37.94 | 35.63 | 37.02 | 1.446M |
| Oct 13, 2026 | 38.17 | 38.35 | 36.08 | 36.28 | 810155.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.015 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0002 |
| Arvinas, Inc. | 6.825 |
| Fulcrum Therapeutics, Inc. | 3.755 |
Price Related Metrics
| PE Ratio | 5.134 |
| Price to Book Value | 2.817 |
| Earnings Yield | 19.48% |
| Market Cap | 4.599B |
| Normalized PE Ratio | 5.134 |